A phase II trial with anti-Lewis-Y monoclonal antibody (hu3S193) for the treatment of platinum resistant/refractory ovarian, fallopian tube and primary peritoneal carcinoma

Abstract Objectives The primary objective was to evaluate the clinical efficacy of hu3S193, a humanized monoclonal antibody against the Lewis-Y antigen, in patients with platinum resistant/refractory ovarian, fallopian tube and primary peritoneal carcinoma. Secondary objectives were safety and pharm...

Full description

Saved in:
Bibliographic Details
Published in:Gynecologic oncology Vol. 138; no. 2; pp. 272 - 277
Main Authors: Smaletz, Oren, Diz, Maria D.P.E, do Carmo, Claudio C, Sabbaga, Jorge, Cunha-Junior, Geraldo F, Azevedo, Sergio J, Maluf, Fernando C, Barrios, Carlos H, Costa, Ronaldo L, Fontana, Ana G, Madrigal, Vivian, Wainstein, Alberto J, Yeda, Fernanda P, Alves, Venâncio A, Moro, Ana M, Blasbalg, Roberto, Scott, Andrew M, Hoffman, Eric W
Format: Journal Article
Language:English
Published: United States Elsevier Inc 01-08-2015
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first